Recurrent Esophageal Cancer Completed Phase 2 Trials for Triapine (DB11940)

IndicationStatusPhase
DBCOND0028797 (Recurrent Esophageal Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000775453-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionTreatment